Endoscopic unroofing is effective for diagnosis and therapy of gastric submucosal tumors: A retrospective study including follow-up

2015 ◽  
Vol 53 (05) ◽  
Author(s):  
W Dolak ◽  
F Wrba ◽  
M Schöniger-Hekele ◽  
M Trauner ◽  
A Püspök
Keyword(s):  
Retrospective Study ◽  
Submucosal Tumors ◽  
Diagnosis And Therapy ◽  
Gastric Submucosal Tumors

Gastric submucosal tumors: Lessons learned from 10-year follow-up

2009 ◽  
Vol 27 (15_suppl) ◽  
pp. e15631-e15631
Author(s):  
A. Sawaki ◽  
N. Mizuno ◽  
T. Takagi ◽  
K. Hara ◽  
T. Nakamura ◽  
...  
Keyword(s):  
Medical Records ◽  
Surgical Intervention ◽  
Lessons Learned ◽  
Long Term Outcomes ◽  
Submucosal Tumors ◽  
Stromal Tumors ◽  
Gastric Submucosal Tumors ◽  
Simultaneous Surgery

e15631 Background: Gastric Submucosal tumors (SMTs) were incidentally discovered esophagogastroduodenoscopy (EGD). However, they have not been studied in detail of epidemiology. Furthermore, no treatment strategy for SMTs has been established with few studies looking into long-term outcomes. The aim of this study is to clarify the clinical features and long-term outcomes of gastric SMT at a single institute for 10-year period. Methods: We performed a total of 5307 EGDs and detected 188 gastric SMTs during 1998. All clinical data including incidence, size and location in stomach were analyzed for the medical records. A retrospective review was conducted for 10-year period for 109 patients and 79 patients were excluded because of simultaneous surgery (3), disappear in follow- up EGD (27), lost of follow-up (49). Results: Gastric SMTs were detected 188 (81 males, 107 females) of 5307 patients (3.5%). Majority size of SMTs was less than 1cm (64%) and SMTs<2cm were 91%. 56% of SMTs located middle one third of stomach, and half (22%) of the remaining SMTs were detected at upper and lower one third, respectively. In 10-year follow-up, 83 of 109 patients were alive at December 2008. One patient was dead of SMT and the remaining 25 patients were dead of other disease till December 2008. Enlargement of SMT was observed in 2 of 109 SMTs (1.8%). Both of them underwent surgical resection and diagnosed as gastrointestinal stromal tumors (GIST). One patient was annually monitored by endoscopy, from 0.6cm to 1.5cm during 4 years, without recurrence for 6 years after surgical intervention. Another didn't undergo regular endoscopy, from 1.8cm to 8cm during 2 years, with recurrence, and consequently died of SMT. Conclusions: The incidence of SMTs is 3.5%, majority (91%) is small (<2cm), and frequent location is middle one third of stomach. Most of SMTs might be managed conservatively, but regular endoscopy is required. No significant financial relationships to disclose.

scholarly journals Gastric Schwannoma: A Tumor Must Be Included in Differential Diagnoses of Gastric Submucosal Tumors

2017 ◽  
Vol 2017 ◽  
pp. 1-8 ◽  
Author(s):  
Bao-guang Hu ◽  
Feng-jie Wu ◽  
Jun Zhu ◽  
Xiao-mei Li ◽  
Yu-ming Li ◽  
...  
Keyword(s):  
Clinical Symptoms ◽  
English Literature ◽  
Differential Diagnoses ◽  
Multicenter Studies ◽  
Submucosal Tumors ◽  
Gastric Schwannoma ◽  
Gastric Submucosal Tumors ◽  
Invasive Techniques ◽  
Slow Growing

Gastric schwannoma (GS) is a rare neoplasm of the stomach. It accounts for 0.2% of all gastric tumors and is mostly benign, slow-growing, and asymptomatic. Due to its rarity, GS is not widely recognized by clinicians, and the precise differential diagnosis between GS and other gastric submucosal tumors remains difficult preoperatively. The present study reports a case of GS misdiagnosed as gastrointestinal stromal tumor and reviews the clinical, imaging, and pathological features, treatment, and follow-up of 221 patients with GS previously reported in the English literature. Although GS is rare, the case reported in the current study highlights the importance of including GS in differential diagnoses of gastric submucosal tumors. Furthermore, the findings of the review suggest that although many cases are asymptomatic, the most common symptoms are abdominal pain or discomfort, not gastrointestinal bleeding, and malignant GSs present with clinical symptoms more commonly. Although large-sample multicenter studies on the efficacy, safety, and oncological outcomes of minimally invasive techniques are required, the findings presented herein may be helpful for clinicians when diagnosing or treating GS.

scholarly journals Endoscopic Resection of Gastric Submucosal Masses by a Dental Floss Traction Method

2019 ◽  
Vol 2019 ◽  
pp. 1-5
Author(s):  
Chunyan Zeng ◽  
Yin Zhu ◽  
Xu Shu ◽  
Nonghua Lv ◽  
Qiang Cai ◽  
...  
Keyword(s):  
Dft Method ◽  
En Bloc Resection ◽  
Bloc Resection ◽  
Clinical Trial Registry ◽  
En Bloc ◽  
Dental Floss ◽  
Submucosal Tumors ◽  
Endoscopic Closure ◽  
Gastric Submucosal Tumors

Background and Aims. ESE (endoscopic submucosal excavation) is widely used for the treatment of digestive diseases. The dental floss traction (DFT) method has been successfully used to facilitate ESE to resect mucosal lesions such as early gastric cancer. DFT has not been used in ESE to remove submucosal masses. This study aimed to examine the efficacy of DFT-assisted ESE (DFT- ESE) for the removal of submucous masses.Methods. From March 2017 to May 2017, a total of 12 patients with gastric submucosal masses at the First Affiliated Hospital of Nanchang University, Jiangxi, China, were enrolled. The tumor characteristics, en bloc resection rates, complications, and outcomes on follow-up were evaluated for all patients.Results. The 12 submucosal tumors were completely removed by DFT- ESE. Nine were gastrointestinal stromal tumors. Two were Schwannoma, located in the greater curvature of the gastric corpus. One was gastric ectopic pancreas. All the resected tumors were removed completely with intact tumor capsules. There was no more bleeding or perforation after the endoscopic closure of the perforation or the wound after the DFT-ESE, and no recurrences were identified at the time of follow-up.Conclusions. The DFT method efficiently and safely facilitated the ESE procedure during the resection of gastric submucosal tumors. This study was registered with Chinese Clinical Trial Registry under Registration numberChiCTR-OOC-15005833).

scholarly journals Preliminary analysis of hybrid laparoscopic procedure for resection of gastric submucosal tumors

2016 ◽  
Vol 43 (2) ◽  
pp. 129-135 ◽  
Author(s):  
PEDRO HENRIQUE LAMBACH CARON ◽  
MARIANA ISMAEL DIAS MARTINS ◽  
PEDRO LUIZ BERTEVELLO
Keyword(s):  
Laparoscopic Resection ◽  
Average Length ◽  
Submucosal Tumor ◽  
Intraoperative Complications ◽  
Clinicopathological Characteristics ◽  
Conversion To Open Surgery ◽  
Submucosal Tumors ◽  
Gastric Submucosal Tumors ◽  
Average Size

ABSTRACT Objective: to evaluate the feasibility, safety and benefits of minimally invasive surgery for resection of gastric submucosal tumor (GSMT). Methods: we conducted a retrospective study of medical records of patients undergoing endoscopy-assisted laparoscopic resection of gastric submucosal tumors (prospectively collected) from 2011 to 2014. We evaluated clinical data, surgical approach, clinicopathological characteristics of the GSMT (size, location, histopathological and immunohistochemical exams), outcome and patients follow-up. Results: we evaluated six patients, 50% male, mean age 52±18 years and common symptoms of heartburn and gastric fullness. All patients underwent hybrid procedure without anatomical impairment of the organ. The average length of stay was 3.5 days and the average size of the tumors was 2.0±0.8cm, five of them (83%) in the proximal third of the stomach. The surgical specimens pathological and immunohistochemistry examination revealed one case of ectopic pancreas (17%), one grade 2 neuroendocrine tumor (17%), one lipoma (17%), one GIST (17%) and two leiomyomas (32%). There were no episodes of tumor rupture or intraoperative complications and no conversion to open surgery. During the postoperative follow-up period, none of the patients had recurrence, metastasis, fistula or stenosis. Conclusion: the results showed that endoscopy-assisted laparoscopic resection is feasible and safe for patients with GSMT. Endoscopy proved to be essential in the location of lesions and as intraoperative support, especially when attempting to preserve the pylorus and cardia during surgery.

scholarly journals Clinical outcomes of non-exposed endoscopic wall-inversion surgery for gastric submucosal tumors: long-term follow-up and functional results

2019 ◽  
Vol 23 (1) ◽  
pp. 154-159 ◽  
Author(s):  
Junya Aoyama ◽  
Osamu Goto ◽  
Hirofumi Kawakubo ◽  
Shuhei Mayanagi ◽  
Kazumasa Fukuda ◽  
...  
Keyword(s):  
Clinical Outcomes ◽  
Functional Results ◽  
Submucosal Tumors ◽  
Gastric Submucosal Tumors ◽  
Long Term Follow Up

Clinical Value of Computer-Assisted Taylor Three-dimensional External Fixation in the Treatment of Tibiofibular Fracture (Preprint)

2020 ◽  
Author(s):  
Hongfeng Sheng ◽  
Weixing Xu ◽  
Bin Xu ◽  
Hongpu Song ◽  
Di Lu ◽  
...  
Keyword(s):  
Retrospective Study ◽  
Internal Fixation ◽  
External Fixation ◽  
External Fixator ◽  
Theoretical Basis ◽  
New Technology ◽  
Three Dimensional ◽  
Computer Assisted ◽  
Clinical Value

UNSTRUCTURED The retrospective study of Taylor's three-dimensional external fixator for the treatment of tibiofibular fractures provides a theoretical basis for the application of this technology. The paper collected 28 patients with tibiofibular fractures from the Department of Orthopaedics in our hospital from March 2015 to June 2018. After the treatment, the follow-up evaluation of Taylor's three-dimensional external fixator for the treatment of tibiofibular fractures and concurrency the incidence of the disease, as well as the efficacy and occurrence of the internal fixation of the treatment of tibial fractures in our hospital. The results showed that Taylor's three-dimensional external fixator was superior to orthopaedics in the treatment of tibiofibular fractures in terms of efficacy and complications. To this end, the thesis research can be concluded as follows: Taylor three-dimensional external fixation in the treatment of tibiofibular fractures is more effective, and the incidence of occurrence is low, is a new technology for the treatment of tibiofibular fractures, it is worthy of clinical promotion.

Hand eczema patients’ knowledge of skin protection following a guided talk—A retrospective study with a follow‐up questionnaire

2019 ◽  
Vol 81 (2) ◽  
pp. 117-123 ◽  
Author(s):  
Yasemin Topal ◽  
Tove Agner ◽  
Janique van der Heiden ◽  
Niels E. Ebbehøj ◽  
Kim K. B. Clemmensen
Keyword(s):  
Retrospective Study ◽  
Hand Eczema ◽  
Skin Protection

Skeletal and Dental Correction and Stability Following LeFort I Advancement in Patients With Cleft Lip and Palate With Mild, Moderate, and Severe Maxillary Hypoplasia

2021 ◽  
pp. 105566562199610
Author(s):  
Buddhathida Wangsrimongkol ◽  
Roberto L. Flores ◽  
David A. Staffenberg ◽  
Eduardo D. Rodriguez ◽  
Pradip. R. Shetye
Keyword(s):  
Retrospective Study ◽  
Outcome Measures ◽  
Cleft Lip ◽  
Outcome Measure ◽  
Cleft Lip And Palate ◽  
Inclusion Criteria ◽  
Maxillary Hypoplasia ◽  
Main Outcome Measure ◽  
Lateral Cephalograms

Objective: This study evaluates skeletal and dental outcomes of LeFort I advancement surgery in patients with cleft lip and palate (CLP) with varying degrees of maxillary skeletal hypoplasia. Design: Retrospective study. Method: Lateral cephalograms were digitized at preoperative (T1), immediately postoperative (T2), and 1-year follow-up (T3) and compared to untreated unaffected controls. Based on the severity of cleft maxillary hypoplasia, the sample was divided into 3 groups using Wits analysis: mild: ≤0 to ≥−5 mm; moderate: <−5 to >−10 mm; and severe: ≤−10 mm. Participants: Fifty-one patients with nonsyndromic CLP with hypoplastic maxilla who met inclusion criteria. Intervention: LeFort I advancement. Main Outcome Measure: Skeletal and dental stability post-LeFort I surgery at a 1-year follow-up. Results: At T2, LeFort I surgery produced an average correction of maxillary hypoplasia by 6.4 ± 0.6, 8.1 ± 0.4, and 10.7 ± 0.8 mm in the mild, moderate, and severe groups, respectively. There was a mean relapse of 1 to 1.5 mm observed in all groups. At T3, no statistically significant differences were observed between the surgical groups and controls at angle Sella, Nasion, A point (SNA), A point, Nasion, B point (ANB), and overjet outcome measures. Conclusions: LeFort I advancement produces a stable correction in mild, moderate, and severe skeletal maxillary hypoplasia. Overcorrection is recommended in all patients with CLP to compensate for the expected postsurgical skeletal relapse.

Sign in / Sign up

Export Citation Format

Share Document